Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00716560 · ClinicalTrials.gov registry record
Nausea and Vomiting In Patients Receiving Consecutive Days of Cisplatin
A clinical trial, sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.
- Terminated
- Registry status
- 8
- Enrollment target
NCT00716560: Clinical Trial study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.
NCT00716560 is a clinical trial that was terminated before completion, run by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00716560 was terminated before completion, sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.
- TERMINATED
- Registry status
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to observe the incidence of nausea with systemic chemotherapy that includes consecutive days (more than one day)of cisplatin medication.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2005-05 |
| Est. Completion | 2009-03 |
Why NCT00716560 stopped before completion
NCT00716560 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00716560 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00716560 about?
NCT00716560 is a clinical study titled "Nausea and Vomiting In Patients Receiving Consecutive Days of Cisplatin". The purpose of this study is to observe the incidence of nausea with systemic chemotherapy that includes consecutive days (more than one day)of cisplatin medication.
What is the current status of trial NCT00716560?
This trial is currently terminated. The enrollment target is 8 participants. The study started on 2005-05. Estimated completion is 2009-03.
Who is sponsoring clinical trial NCT00716560?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, which has 138 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia